These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4192343)

  • 21. [Antitubercular chemoprevention: hepatotoxicity and therapeutic compliance].
    Hortoneda Giménez M; Alfonso Sánchez JL; Cortés Vizcaíno C; Sabater Pons A
    An Med Interna; 1993 Dec; 10(12):587-9. PubMed ID: 8049323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemolytic anaemia in a patient taking thioacetazone.
    Masel MA; Johnston NG
    Med J Aust; 1968 Nov; 2(19):840-3. PubMed ID: 4178143
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hepatotoxicity of dibekacin: correlation between the ultrastructural aspects and hemato-chemical parameters in an experimental model].
    Butturini L; Boiardi L; Menozzi I; Bernardi S; Martines G
    G Clin Med; 1985; 66(11-12):441-50. PubMed ID: 3835088
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatotoxicity due to treatment with papaverine. Report of four cases.
    Ronnov-Jessen V; Tjernlund A
    N Engl J Med; 1969 Dec; 281(24):1333-5. PubMed ID: 5355438
    [No Abstract]   [Full Text] [Related]  

  • 25. [The therapeutic efficacy of a streptomycin-hydrazide-thiacetazone regimen with different dosages of thiacetazone in pulmonary tuberculosis].
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Apr; 9(2):72-6, 125. PubMed ID: 2427291
    [No Abstract]   [Full Text] [Related]  

  • 26. Isoniazid hepatotoxicity and acetylation during tuberculosis chemoprophylaxis.
    Myles RK
    Am Rev Respir Dis; 1980 Sep; 122(3):505-6. PubMed ID: 6106445
    [No Abstract]   [Full Text] [Related]  

  • 27. [Relationship between the endogenous interferon IFN-gamma level and risk of hepatotoxic liver damage in tuberculosis patients].
    Sukhanov DS; Okovityĭ SV; Demidik SN; Ivanov AK; Romantsov MG
    Eksp Klin Farmakol; 2012; 75(6):40-3. PubMed ID: 22891441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Change in serum transaminase activity under the effect of a vulcalent of phenolformaldehyde resins].
    Beliaeva NN; Kozlova TA
    Gig Sanit; 1972 Mar; 37(3):120. PubMed ID: 4645310
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative efficacy of clinical use of reamberin, remaxol and ademethionine in patients with tuberculosis of the respiratory organs and liver drug-injury].
    Sukhanov DS; Pavlova MV; Iablonskiĭ PK; Vinogradova TI
    Antibiot Khimioter; 2013; 58(1-2):13-8. PubMed ID: 24640140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The influence of rifampicin upon the metabolism of isoniazid (author's transl)].
    Modai J; Coulaud JP; Vivien JM; Berthelot G; Bergogne-Berezin E
    Nouv Presse Med; 1978 Apr; 7(15):1263-7. PubMed ID: 662655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isoniazid with thiacetazone in the treatment of pulmonary tuberculosis in East Africa.
    East Afr Med J; 1972 Jan; 49(1):3-6. PubMed ID: 4112873
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatotoxicity of sulphamethoxyridazine.
    Konttinen A
    Br Med J; 1972 Apr; 2(5806):168. PubMed ID: 5017317
    [No Abstract]   [Full Text] [Related]  

  • 33. [Behavior of some parameters of liver damage under the influence of carbon tetrachloride, allyl alcohol and noradrenaline].
    Strubelt O; Siegers CP; Breining H
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):461-2. PubMed ID: 4253879
    [No Abstract]   [Full Text] [Related]  

  • 34. Quinidine hepatotoxicity. A report of a case and review of the literature.
    Koch MJ; Seeff LB; Crumley CE; Rabin L; Burns WA
    Gastroenterology; 1976 Jun; 70(6):1136-40. PubMed ID: 1269875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Liver parenchyma damage by treatment with desferrioxamine B].
    Schmidt UJ; Kranz D; Brüschke G; Kalbe I; Rürup B
    Dtsch Gesundheitsw; 1969 May; 24(21):995-6. PubMed ID: 5385364
    [No Abstract]   [Full Text] [Related]  

  • 36. Intermittent chemotherapy with thiacetazone and isoniazid in the treatment of pulmonary tuberculosis.
    Krishnaswami KV
    Indian J Chest Dis Allied Sci; 1977 Oct; 19(4):177-87. PubMed ID: 77844
    [No Abstract]   [Full Text] [Related]  

  • 37. Rifampin in initial treatment of pulmonary tuberculosis. A U.S. Public Health Service tuberculosis therapy trial.
    Newman R; Doster B; Murray FJ; Ferebee S
    Am Rev Respir Dis; 1971 Apr; 103(4):461-76. PubMed ID: 4994459
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatotoxicity due to etanercept abated after dose reduction in a patient with pustular psoriasis and without compromised efficacy.
    Li Z; Xiao S; Ren J; Zhang Y; Tu C; Ji F
    Rev Esp Enferm Dig; 2014 Aug; 106(7):492-3. PubMed ID: 25490172
    [No Abstract]   [Full Text] [Related]  

  • 39. Thiacetazone-isoniazid combination in the treatment of pulmonary tuberculosus.
    Mital OP; Ramalingam JT; Agarwala MC
    J Indian Med Assoc; 1968 May; 50(10):468-73. PubMed ID: 4178704
    [No Abstract]   [Full Text] [Related]  

  • 40. Concurrent comparison of an unsupervised daily oral regimen of thiacetazone plus isoniazid and a fully supervised twice-weekly regimen of streptomycin plus isoniazid in the domiciliary treatment of pulmonary tuberculosis--a co-operative investigation.
    Menon K
    Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():131-2. PubMed ID: 4143180
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.